Regeneron Pharmaceuticals, Inc.

Capital Investment Advisors, LLC REGN

Report date

3/31/2026

Quarter

2026 Q1

Filed

4/17/2026

Shares

569

Value ($000)

439

Weight

0.0%

2022 Q1 - 2026 Q1 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q1	4/17/2026	439	0.0%	569	3/31/2026
2025 Q4	1/13/2026	409	0.0%	530	12/31/2025
2025 Q3	10/23/2025	268	0.0%	477	9/30/2025
2025 Q1	4/14/2025	278	0.0%	438	3/31/2025
2024 Q4	1/13/2025	217	0.0%	304	12/31/2024
2024 Q3	10/17/2024	331	0.0%	315	9/30/2024
2024 Q2	7/12/2024	310	0.0%	295	6/30/2024
2024 Q1	4/15/2024	281	0.0%	292	3/31/2024
2023 Q4	1/5/2024	259	0.0%	295	12/31/2023
2023 Q3	10/16/2023	237	0.0%	288	9/30/2023
2023 Q2	7/11/2023	220	0.0%	306	6/30/2023
2023 Q1	4/10/2023	256	0.0%	311	3/31/2023
2022 Q4	1/5/2023	207	0.0%	287	12/31/2022
2022 Q3	10/5/2022	205	0.0%	298	9/30/2022
2022 Q1	4/13/2022	215	0.0%	308	3/31/2022